Tranexamic acid (TXA), a lysine analogue and antifibrinolytic agent, inhibits the binding of plasminogen originating from endothelial cells to keratinocytes resulting in the diminution of melanocyte activators production (e.g., arachidonic acid, prostaglandins, leukotrienes, -MSH) [6, 27, 90]
The long-lasting effects observed in these models suggest the potential for therapies that provide sustained benefits
The hypothalamus, located above the midbrain, plays a central role in integrating signals regarding food intake, energy balance, and body weight
the AnglV analogue treatment-induced increase in spine head width suggests facilitated neurotransmission
DACRA KBP-088 showed greater efficacy relative to davalintide regarding in vitro receptor pharmacology and in vivo efficacy of food intake and body weight (204)
Cell death occurred within 15 minutes with 0.3% polidocanol (POL) or 0.1% sodium tetradecyl sulfate (STS)